Trials / Terminated
TerminatedNCT00238082
The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease
The Effect of HFA-beclomethasone Dipropionate on Static Lung Volumes in COPD
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- National Jewish Health · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
This is an investigator-sponsored research study to evaluate if treatment with HFA-134a beclomethasone (QVAR) has an effect on peripheral (or outer) airway inflammation and airway "remodeling" or scarring in subjects with COPD. Approximately 20 subjects with COPD will participate for approximately 7 weeks, with 10 receiving an active (BDP) inhaler with HFA-134a and 10 receiving a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HFA-134A Beclomethasone DIpropionate (QVAR) |
Timeline
- Start date
- 1999-11-01
- Primary completion
- 2005-02-01
- Completion
- 2005-02-01
- First posted
- 2005-10-13
- Last updated
- 2017-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00238082. Inclusion in this directory is not an endorsement.